Termpong Reanpang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Termpong Reanpang has a total of 20 co-authors. Here are the top co-authors by number of shared publications:
- Amaraporn Rerkasem
Research Institute for Health Sciences, Chiang Mai University, Chiang Mai 50200, Thailand
1 shared publication - Boonying Siribumrungwong
Division of Vascular Surgery, Department of Surgery, Faculty of Medicine Pathum Thani 10120 Thammasat University
1 shared publication - Busaba Chuatrakoon
Integrated Neuro-Musculoskeletal, Chronic Disease, and Aging Research Engagement Center (ICARE Center), Department of Physical Therapy, Faculty of Associated Medical Sciences, Chiang Mai University, Chiang Mai 50200, Thailand
1 shared publication - José Guilherme Behrensdorf Derraik
Department of Paediatrics: Child and Youth Health School of Medicine, Faculty of Medical and Health Sciences, University of Auckland Auckland New Zealand
1 shared publication - Khun Phisitbuntoon
Integrated Neuro-Musculoskeletal, Chronic Disease, and Aging Research Engagement Center (ICARE Center), Department of Physical Therapy, Faculty of Associated Medical Sciences, Chiang Mai University, Chiang Mai 50200, Thailand
1 shared publication - Kittipan Rerkasem
Research Institute for Health Sciences, Chiang Mai University
1 shared publication
Latest Publications
- Open Access
- 6 June 2026
- Published by MDPI AG in Diagnostics
- Vol. 16 (12) , 1750
Functional Walking Capacity as a Screening Indicator for Peripheral Arterial Disease in Patients with Type 2 Diabetes Mellitus: Development of a Clinical Risk Equation
Background/Objectives: Peripheral arterial disease (PAD) is a common complication in patients with type 2 diabetes mellitus (T2DM) and is associated with substantial morbidity. Standard diagnostic tools such as the ankle–brachial index (ABI) may be limited in certain clinical settings. Therefore, simple and practical approaches for identifying individuals at increased risk of PAD are needed. This study aimed to examine the association between functional walking capacity and PAD and to develop a simple clinical risk equation for identifying PAD risk in patients with T2DM. Methods: A cross-sectional analytical study was conducted in 223 patients with T2DM attending an outpatient clinic. PAD was diagnosed using ABI and toe–brachial index measurements. Functional walking capacity was assessed using the Incremental Shuttle Walk Test (ISWT). Multivariable logistic regression analysis was used to identify factors associated with PAD and to develop a risk equation. Model performance was evaluated using receiver operating characteristic (ROC) curve analysis. Results: An ISWT distance ≤ 215 m was independently associated with PAD (OR = 1.96, 95% CI 1.10–3.50, p = 0.022). The developed model demonstrated fair discriminative ability (AUC = 0.67). At a probability cutoff of 0.57, the model showed a sensitivity of 53.8% and a specificity of 76.4%. Conclusions: Reduced functional walking capacity was associated with PAD in patients with T2DM. The proposed equation demonstrated fair discriminatory ability and may provide preliminary information for PAD risk identification; however, further validation is required before clinical implementation.
- 6 June 2026
- Published by MDPI AG in Diagnostics
- Vol. 16 (12) , 1750
Open AccessFunctional Walking Capacity as a Screening Indicator for Peripheral Arterial Disease in Patients with Type 2 Diabetes Mellitus: Development of a Clinical Risk Equation
Background/Objectives: Peripheral arterial disease (PAD) is a common complication in patients with type 2 diabetes mellitus (T2DM) and is associated with substantial morbidity. Standard diagnostic tools such as the ankle–brachial index (ABI) may be limited in certain clinical settings. Therefore, simple and practical approaches for identifying individuals at increased risk of PAD are needed. This study aimed to examine the association between functional walking capacity and PAD and to develop a simple clinical risk equation for identifying PAD risk in patients with T2DM. Methods: A cross-sectional analytical study was conducted in 223 patients with T2DM attending an outpatient clinic. PAD was diagnosed using ABI and toe–brachial index measurements. Functional walking capacity was assessed using the Incremental Shuttle Walk Test (ISWT). Multivariable logistic regression analysis was used to identify factors associated with PAD and to develop a risk equation. Model performance was evaluated using receiver operating characteristic (ROC) curve analysis. Results: An ISWT distance ≤ 215 m was independently associated with PAD (OR = 1.96, 95% CI 1.10–3.50, p = 0.022). The developed model demonstrated fair discriminative ability (AUC = 0.67). At a probability cutoff of 0.57, the model showed a sensitivity of 53.8% and a specificity of 76.4%. Conclusions: Reduced functional walking capacity was associated with PAD in patients with T2DM. The proposed equation demonstrated fair discriminatory ability and may provide preliminary information for PAD risk identification; however, further validation is required before clinical implementation.
- Open Access
- 29 December 2023
- Published by MDPI AG in Antibiotics
- Vol. 13 (1) , 35
A COVID-19 Silver Lining—Decline in Antibiotic Resistance in Ischemic Leg Ulcers during the Pandemic: A 6-Year Retrospective Study from a Regional Tertiary Hospital (2017–2022)
Antibiotic resistance (AR) associated with chronic limb-threatening ischemia (CLTI) poses additional challenges for the management of ischemic leg ulcers, increasing the likelihood of severe outcomes. This study assessed AR prevalence in bacteria isolated from CLTI-associated leg ulcers before (1 January 2017–10 March 2020; n = 69) and during (11 March 2020–31 December 2022; n = 59) the COVID-19 pandemic from patients admitted with positive wound cultures to a regional hospital in Chiang Mai (Thailand). There was a marked reduction in AR rates from 78% pre-pandemic to 42% during the pandemic (p < 0.0001), with rates of polymicrobial infections 22 percentage points lower (from 61% to 39%, respectively; p = 0.014). There were reduced AR rates to amoxicillin/clavulanate (from 42% to 4%; p < 0.0001) and ampicillin (from 16% to 2%; p = 0.017), as well as multidrug resistance (19% to 8%; p = 0.026). Factors associated with increased AR odds were polymicrobial infections (adjusted odds ratio (aOR) 5.6 (95% CI 2.1, 15.0); p = 0.001), gram-negative bacteria (aOR 7.0 (95% CI 2.4, 20.5); p < 0.001), and prior use of antibiotics (aOR 11.9 (95% CI 1.1, 128.2); p = 0.041). Improvements in infection control measures and hygiene practices in the community during the pandemic were likely key factors contributing to lower AR rates. Thus, strategic public health interventions, including community education on hygiene and the informed use of antibiotics, may be crucial in mitigating the challenges posed by AR in CLTI. Further, advocating for more judicious use of empirical antibiotics in clinical settings can balance effective treatment against AR development, thereby improving patient outcomes.
- 29 December 2023
- Published by MDPI AG in Antibiotics
- Vol. 13 (1) , 35
Open AccessA COVID-19 Silver Lining—Decline in Antibiotic Resistance in Ischemic Leg Ulcers during the Pandemic: A 6-Year Retrospective Study from a Regional Tertiary Hospital (2017–2022)
Antibiotic resistance (AR) associated with chronic limb-threatening ischemia (CLTI) poses additional challenges for the management of ischemic leg ulcers, increasing the likelihood of severe outcomes. This study assessed AR prevalence in bacteria isolated from CLTI-associated leg ulcers before (1 January 2017–10 March 2020; n = 69) and during (11 March 2020–31 December 2022; n = 59) the COVID-19 pandemic from patients admitted with positive wound cultures to a regional hospital in Chiang Mai (Thailand). There was a marked reduction in AR rates from 78% pre-pandemic to 42% during the pandemic (p < 0.0001), with rates of polymicrobial infections 22 percentage points lower (from 61% to 39%, respectively; p = 0.014). There were reduced AR rates to amoxicillin/clavulanate (from 42% to 4%; p < 0.0001) and ampicillin (from 16% to 2%; p = 0.017), as well as multidrug resistance (19% to 8%; p = 0.026). Factors associated with increased AR odds were polymicrobial infections (adjusted odds ratio (aOR) 5.6 (95% CI 2.1, 15.0); p = 0.001), gram-negative bacteria (aOR 7.0 (95% CI 2.4, 20.5); p < 0.001), and prior use of antibiotics (aOR 11.9 (95% CI 1.1, 128.2); p = 0.041). Improvements in infection control measures and hygiene practices in the community during the pandemic were likely key factors contributing to lower AR rates. Thus, strategic public health interventions, including community education on hygiene and the informed use of antibiotics, may be crucial in mitigating the challenges posed by AR in CLTI. Further, advocating for more judicious use of empirical antibiotics in clinical settings can balance effective treatment against AR development, thereby improving patient outcomes.